CXCL10 as a macrophage-regulating chemokine may contribute to the migration of immune cells, inflammation, and clinical course of BPD, and could thereby serve as a biomarker of BPD in very premature infants. Here, CXCL10 is linked to bronchopulmonary dysplasia.